Evidence map›Paper›PMID 35205688›Full record

ArticleCancers2022

The Prognostic Role of Intratumoral Stromal Content in Lobular Breast Cancer.

Carina Forsare, Sara Vistrand, Anna Ehinger, Kristina Lövgren, Lisa Rydén, Mårten Fernö, Ulrik Narbe

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Carina ForsareDivision of Oncology, Department of Clinical Sciences Lund, Lund University, SE-223 81 Lund, Sweden.
Sara VistrandDepartment of Oncology, Växjö Central Hospital, SE-352 34 Växjö, Sweden.
Anna EhingerDivision of Oncology, Department of Clinical Sciences Lund, Lund University, SE-223 81 Lund, Sweden.ORCID 0000-0001-9225-7396
Kristina LövgrenDivision of Oncology, Department of Clinical Sciences Lund, Lund University, SE-223 81 Lund, Sweden.
Lisa RydénDivision of Surgery, Department of Clinical Sciences Lund, Lund University, SE-223 81 Lund, Sweden.ORCID 0000-0001-7515-3130
Mårten FernöDivision of Oncology, Department of Clinical Sciences Lund, Lund University, SE-223 81 Lund, Sweden.
Ulrik NarbeDivision of Oncology, Department of Clinical Sciences Lund, Lund University, SE-223 81 Lund, Sweden.ORCID 0000-0002-7062-6581
Lund University · SEVäxjö Kommun · SE

Funding

Anna and Edwin Bergers Foundation No numberGovernmental Funding of Clinical Research within National Health Service (ALF) 2021-40304Kronoberg County Council´s Research and Development Foundation No numberThe Cancer Foundation Kronoberg 2016/422The Swedish Breast Cancer Association 2015/909The Swedish Cancer Society No number
6 · The paper itself

Abstract

Previous studies have shown that high intratumoral stromal content is associated with a worse prognosis in breast cancer, especially in the triple-negative subtype. However, contradictory results have been reported for estrogen-receptor-positive (ER+) breast cancer, indicating that the prognostic role of intratumoral stromal content may be subtype-dependent. In this study, we investigated the importance of intratumoral stromal content for breast cancer-specific mortality (BCM) in a well-defined subgroup (

Indexed as

intratumoral stromalobular breast cancerlong-term prognosis

Identifiers

PMID35205688
PMCPMC8870094
OpenAlexW4212773371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.